Abstract:There remains a large need for a greater understanding of the metastatic process within the prostate cancer field. Our research aims to understand the adaptive (ergo potentially metastatic) responses of cancer to changing microenvironments. Emerging evidence has implicated a role of the Polyaneuploid Cancer Cell (PACC) state in metastasis, positing the PACC state as capable of conferring metastatic competency. Mounting in vitro evidence supports increased metastatic potential of cells in the PACC state. Additionally, our recent retrospective study of prostate cancer patients revealed that PACC presence in the prostate at the time of radical prostatectomy was predictive of future metastatic progression. To test for a causative relationship between PACC state biology and metastasis, we leveraged a novel method designed for flow-cytometric detection of circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) in subcutaneous, caudal artery, and intracardiac mouse models of metastasis. This approach provides both quantitative and qualitative information about the number and PACC-status of recovered CTCs and DTCs. Collating data from all models, we found that 74% of recovered CTCs and DTCs were in the PACC state. In vivo colonization assays proved PACC populations can regain proliferative capacity at metastatic sites following dormancy. Additional direct and indirect mechanistic in vitro analyses revealed a PACC-specific partial Epithelial-to-Mesenchymal-Transition phenotype and a pro-metastatic secretory profile, together providing preliminary evidence that PACCs are mechanistically linked to metastasis.

What problem does this paper attempt to address?

This paper attempts to address the relationship between the polyaneuploid cancer cell (PACC) state and the metastatic ability in prostate cancer. Specifically, the study aims to explore whether the PACC state can endow cancer cells with a higher metastatic potential and verify whether this state is indeed associated with enhanced metastatic ability in vivo. ### Research Background - **Metastasis in Prostate Cancer**: Although early diagnosis is helpful for the radical treatment of local diseases, once prostate cancer metastasizes, the condition becomes fatal and incurable. The metastasis process involves multiple steps, including the invasion of metastatic cells in the primary tumor into local tissues, entry into blood vessels, survival in the circulatory system, extravasation into distal organs and colonization there. - **Characteristics of the PACC State**: The PACC state is a transient and adaptive cellular response caused by genotoxic stress, characterized by an increase in genomic content, accompanied by an indefinite pause in cell division. Cells in this state usually show significant nuclear and cytoplasmic enlargement, forming a unique morphological phenotype. - **Relationship between the PACC State and Metastasis**: Previous studies have shown that the PACC state may be associated with an increased metastatic potential in various cancers such as breast cancer and prostate cancer. Clinical studies have also found that the presence of PACC is associated with more advanced diseases and a higher risk of metastasis. ### Research Objectives - **Verify Causal Relationship**: By using multiple mouse models (including subcutaneous injection, tail - vein injection, and intracardiac injection models), the researchers aim to verify whether the PACC state directly leads to a higher metastatic ability. - **Mechanism Exploration**: In addition to verifying the causal relationship, the study also explores how the PACC state enhances the metastatic potential through partial - epithelial - to - mesenchymal - transition (pEMT) and other secreted factor mechanisms. ### Main Findings - **PACC State in CTCs and DTCs**: In different models, the study found that most of the recovered circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) are in the PACC state. For example, in the subcutaneous model, 75% of CTCs and 80% of DTCs are in the PACC state. - **Metastatic Potential of PACC**: Through the tail - vein injection experiment, the study found that reducing the proportion of baseline PACC does not change the proportion of PACC in the recovered DTCs, suggesting that non - PACC cells may transform into the PACC state in vivo. - **Colonization Ability of PACC**: The study also demonstrated that the PACC population can still recover its proliferative ability after a long - term dormancy, which further supports the relationship between the PACC state and enhanced metastatic ability. ### Conclusion This study provides strong evidence that the PACC state is not only associated with an increased metastatic potential in prostate cancer, but also this relationship may be causal. The research results reveal that the PACC state increases the metastatic risk of cancer cells through direct and indirect mechanisms working together. These findings are of great significance for understanding the metastasis mechanism of prostate cancer and may provide a theoretical basis for the development of new treatment strategies.

Cells in the Polyaneuploid Cancer Cell State are Pro-Metastatic

Abstract 2757: Investigating regulatory drivers of prostate cancer metastasis in circulating tumor cells

Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progression

Defining cellular population dynamics at single-cell resolution during prostate cancer progression

The role of heterogeneous environment and docetaxel gradient in the emergence of polyploid, mesenchymal and resistant prostate cancer cells

Abstract 5514: Crosstalk between prostatic epithelial cells and the tumor microenvironment drives cancer progression and metastasis

Anti-androgen Therapy Induces Transcriptomic Reprogramming in Metastatic Castration-Resistant Prostate Cancer in a Murine Model.

Poly-aneuploid cancer cells promote evolvability, generating lethal cancer

Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer

Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models

Distinct mesenchymal cell states mediate prostate cancer progression

The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.

Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells

Polyploid cancer cells reveal signatures of chemotherapy resistance

Abstract 298: Contribution of cancer associated fibroblasts to treatment response and resistance in high-risk multifocal prostate cancer

Mesenchymal and Stem-Like Prostate Cancer Linked to Therapy-Induced Lineage Plasticity and Metastasis

Tumor microenvironment promotes prostate cancer cell dissemination via the Akt/mTOR pathway

Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts

Abstract 1991: Leiomyosarcoma poly-aneuploid cancer cells form in response to chemotherapy, contribute to chemoresistance, and lead to higher rates of metastatic recurrence

Cell Plasticity and Prostate Cancer: The Role of Epithelial–Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance